(Q45163955)

English

Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions

scientific article published in July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Roger J F Baskett

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Maurice A Nanton

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Andrew E Warren

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

David B Ross

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

The Journal of Thoracic and Cardiovascular Surgery

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

126

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

232-239

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Aortic valve replacement with cryopreserved aortic allograft: ten-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

An analysis of valve re-replacement after aortic valve replacement with biologic devices

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Human aortic valve allografts elicit a donor-specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Humoral immune response to human aortic valve homografts

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Evidence for rejection of homograft cardiac valves in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thorac

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Right ventricular outflow reconstruction with cryopreserved homografts in pediatric patients: intermediate-term follow-up with serial echocardiographic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Prevention of allograft heart valve failure in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Decellularized human valve allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Interstitial cellular and matrix restoration of cardiac valves after cryopreservation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Early results of right ventricular-pulmonary artery conduits in patients under 1 year of age

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

The Ross procedure is the procedure of choice for congenital aortic valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

Does histocompatibility affect homograft valve function after the Ross procedure?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2900210-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-5223(03)00210-1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45163955&oldid=2068753471"